TC BioPharm
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TC BioPharm and buy or sell other stocks, ETFs, and their options commission-free!About TCBP
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.
CEOBryan Kobel
CEOBryan Kobel
Employees39
Employees39
HeadquartersMotherwell, North Lanarkshire
HeadquartersMotherwell, North Lanarkshire
Founded2013
Founded2013
Employees39
Employees39
TCBP Key Statistics
Market cap9.92K
Market cap9.92K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume8.75K
Average volume8.75K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$521.60
52 Week high$521.60
52 Week low$0.5017
52 Week low$0.5017
Stock Snapshot
As of today, TC BioPharm(TCBP) shares are valued at $0.32. The company's market cap stands at 9.92K.
On 2025-12-10, TC BioPharm(TCBP) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for TC BioPharm(TCBP) stock has reached 0, versus its average volume of 8.75K.
Over the past 52 weeks, TC BioPharm(TCBP) stock has traded between a high of $521.60 and a low of $0.50.
Over the past 52 weeks, TC BioPharm(TCBP) stock has traded between a high of $521.60 and a low of $0.50.